SARS
- Rheumatoid Arthritis
Anti-rheumatic drug as a potential candidate for treating COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces inflammatory cytokine storms. But an FDA-approved anti-rheumatic drug, Auranofin, used to…
Read More » - Rheumatoid Arthritis
Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection
In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with…
Read More » - Rheumatoid Arthritis
Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes
Researchers in the UK have conducted a large population-based study showing that people with immune-mediated inflammatory diseases (IMIDs) appear to…
Read More » - Rheumatoid Arthritis
COVID-19 vaccine elicits antibody responses in nearly 9 out of 10 people taking immunosuppressants
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were…
Read More » - Rheumatoid Arthritis
Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases
A recent study published on the preprint server medRxiv* discusses the clinical characteristics and outcomes of patients with systemic autoimmune…
Read More »
